ImmusanT
BioTech/Drugs - Cambridge, MA, US
ImmusanT Employees
ImmusanT Details
ImmusanT is a privately held biotechnology company focused on protecting patients with celiac disease against the effects of gluten. By harnessing new discoveries in immunology ImmusanT aims to improve diagnosis and medical management of celiac disease byprotecting against the effects of gluten exposure while patients maintain a gluten free diet. The company is developing Nexvax2®, a therapeutic vaccine for celiac disease, and diagnostic and monitoring tools to improve celiac disease management. ImmusanT's targeted immunotherapy discovery platform can be applied to a variety of autoimmune diseases. Founded in 2010, ImmusanT is backed by Vatera Healthcare Partners. More information may be found at www.ImmusanT.com, or follow @ImmusanT on Twitter.
ImmusanT Technologies
Email Providers
Outlook
Other
Microsoft Office 365
Hosting
DigitalOcean